The Kraepelinian dichotomy – going, going... but still not gone

Summary Recent genetic studies reinforce the view that current approaches to the diagnosis and classification of major psychiatric illness are inadequate. These findings challenge the distinction between schizophrenia and bipolar disorder, and suggest that more attention should be given to the relationship between the functional psychoses and neurodevelopmental disorders such as autism. We are entering a transitional period of several years during which psychiatry will need to move from using traditional descriptive diagnoses to clinical entities (categories and/or dimensions) that relate more closely to the underlying workings of the brain.

[1]  Thomas W. Mühleisen,et al.  Large recurrent microdeletions associated with schizophrenia , 2008, Nature.

[2]  N. Craddock,et al.  The beginning of the end for the Kraepelinian dichotomy , 2005, British Journal of Psychiatry.

[3]  John P. Rice,et al.  Singleton deletions throughout the genome increase risk of bipolar disorder , 2009, Molecular Psychiatry.

[4]  M. Rietschel,et al.  Dissecting the phenotype in genome-wide association studies of psychiatric illness , 2009, British Journal of Psychiatry.

[5]  P. Visscher,et al.  Rare chromosomal deletions and duplications increase risk of schizophrenia , 2008, Nature.

[6]  G. Kirov,et al.  Rare copy number variants: a point of rarity in genetic risk for bipolar disorder and schizophrenia. , 2010, Archives of general psychiatry.

[7]  W. Gaebel,et al.  Modern modularity and the road towards a modular psychiatry , 2008, European Archives of Psychiatry and Clinical Neuroscience.

[8]  M C O'Donovan,et al.  The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia , 2009, Molecular Psychiatry.

[9]  Stephan Heckers,et al.  Is schizoaffective disorder a useful diagnosis? , 2009, Current psychiatry reports.

[10]  K. Kendler Reflections on the Relationship Between Psychiatric Genetics and Psychiatric Nosology , 2006 .

[11]  P. Donnelly,et al.  Strong genetic evidence for a selective influence of GABAA receptors on a component of the bipolar disorder phenotype , 2008, Molecular Psychiatry.

[12]  Manuel A. R. Ferreira,et al.  Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder , 2008, Nature Genetics.

[13]  C. Spencer,et al.  Identification of loci associated with schizophrenia by genome-wide association and follow-up , 2008, Nature Genetics.

[14]  O. Sporns,et al.  Complex brain networks: graph theoretical analysis of structural and functional systems , 2009, Nature Reviews Neuroscience.

[15]  J. Stockman,et al.  Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study , 2010 .

[16]  V. Moskvina,et al.  Genetic utility of broadly defined bipolar schizoaffective disorder as a diagnostic concept , 2009, British Journal of Psychiatry.

[17]  N. Craddock,et al.  Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk , 2009, Molecular Psychiatry.

[18]  N. Craddock,et al.  Rethinking psychosis: the disadvantages of a dichotomous classification now outweigh the advantages. , 2007, World psychiatry : official journal of the World Psychiatric Association.

[19]  P. Visscher,et al.  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder , 2009, Nature.

[20]  Jessica R. Wolff,et al.  Microduplications of 16p11.2 are Associated with Schizophrenia , 2009, Nature Genetics.

[21]  D. Rujescu,et al.  Neurexin 1 (NRXN1) deletions in schizophrenia. , 2009, Schizophrenia bulletin.

[22]  B. van der Zwaag,et al.  Contact in the genetics of autism and schizophrenia , 2009, Trends in Neurosciences.

[23]  Nick Craddock,et al.  Psychosis genetics: modeling the relationship between schizophrenia, bipolar disorder, and mixed (or "schizoaffective") psychoses. , 2009, Schizophrenia bulletin.

[24]  G. Kirov,et al.  Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. , 2009, Human molecular genetics.

[25]  Jiannis Ragoussis,et al.  A 15q13.3 microdeletion segregating with autism , 2009, European Journal of Human Genetics.

[26]  A. Singleton,et al.  Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia , 2008, Science.

[27]  S. Mccarroll,et al.  Copy-number variation and association studies of human disease , 2007, Nature Genetics.

[28]  N. Craddock,et al.  Diagnosis of functional psychoses: time to face the future , 2009, The Lancet.

[29]  D. Rujescu,et al.  Neurexin 1 ( NRXN 1 ) Deletions in Schizophrenia , 2009 .

[30]  Robin M. Murray,et al.  A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder , 2004, Schizophrenia Research.

[31]  Joshua M. Korn,et al.  Association between microdeletion and microduplication at 16p11.2 and autism. , 2008, The New England journal of medicine.